未找到相关数据
Phase II study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676)
被引：0
作者：
Necchi, Andrea
Giannatempo, Patrizia
Mariani, Luigi
Fina, Emanuela
Nicolai, Nicola
Pennati, Marzia
Zaffaroni, Nadia
Fare, Elena
Piva, Luigi
Biasoni, Davide
Catanzaro, Mario
Torelli, Tullio
Stagni, Silvia
Maffezzini, Massimo
Colecchia, Maurizio
Paolini, Biagio
Cappelletti, Vera
Daidone, Maria Grazia
Gianni, Alessandro M.
Salvioni, Roberto
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Unit Clin Epidemiol & Trial Org, Milan, Italy
[3] Univ Milan, Milan, Italy
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
305
引用
收藏
页数：1
相关论文